Béjaoui N, Pagé M, Nöel C
Department of Biochemistry, Faculty of Medicine, Université Laval, Québec, Canada.
Anticancer Res. 1991 Nov-Dec;11(6):2211-3.
We have evaluated the effectiveness of daunorubicin against an SCCL cell line (NCI-H69) after conjugation to transferrin. Our results show that the conjugate is at least 10 times more active than the free drug in this in vitro system.
我们评估了柔红霉素与转铁蛋白结合后对一种小细胞肺癌细胞系(NCI-H69)的有效性。我们的结果表明,在这个体外系统中,该偶联物的活性至少比游离药物高10倍。